Skip to content

GLP-1 tracker

GLP-1 Tracker App for Doses & Supply

Log semaglutide, tirzepatide or any GLP-1 you take, with schedules, supply and history in one place.

Peptade Home screen: a countdown to the next scheduled dose, the last dose logged, your stack, today's schedule and application sites on a body map
Log from the next-dose card
Schedule and next dose

Published by Peptade · GLP-1 tracker · Updated September 2026

A dedicated GLP-1 tracker keeps one place for the schedule you set, the history you've logged, and how much supply remains. You don't need a separate app or a paper log to see all three together.

Add a GLP-1 once, and log each dose from the next-dose card on Home. The tracker keeps the running history and the pen or vial's remaining supply, calculated from what you've logged.

For an FDA-approved GLP-1, Peptade's research library states what the medicine is approved for and notes that your prescriber decides your dose. The tracker itself only records what you've already decided and logged — nothing is proposed for you.

Built for the GLP-1 routine

Frequently asked questions

Semaglutide, tirzepatide, liraglutide and dulaglutide — all FDA-approved — are in the library, or add a custom entry if yours isn't. The library also lists investigational compounds such as retatrutide, for reference.

No. You log the dose you and your prescriber have already decided on. Peptade's library states what an FDA-approved GLP-1 is approved for, and that your prescriber determines your dose.

Yes. Add each GLP-1 you're following, and each keeps its own dose, supply and history.

No. Every value in the tracker — amount, schedule, supply — comes from what you enter, not from a pharmacy or prescription record.

Keep exploring

Track it in Peptade.

Doses, schedules, cycles, injection sites and supply — one app, free to download on iOS and Android.

Peptade is for tracking and education only. It is not medical advice, a diagnosis, or a prescription, and it does not tell you to take, start, stop or buy anything. See the Medical Disclaimer.